title: A marked increase in myeloblasts in the peripheral blood of a patient with Burkitt lymphoma following granulocyte colony-stimulating factor administration.
authors.affiliation: Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. takamaz@med3.m.kanazawa-u.ac.jp
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Takamatsu
authors.forename: Hirohito
authors.initials: H
authors.lastname: Yamazaki
authors.forename: Takeshi
authors.initials: T
authors.lastname: Yamashita
authors.forename: Akiyoshi
authors.initials: A
authors.lastname: Takami
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Okumura
authors.forename: Shinji
authors.initials: S
authors.lastname: Nakao
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002051:Burkitt Lymphoma / Q000097:blood* / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D017809:Fatal Outcome; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D042381:Granulocyte Precursor Cells / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D011994:Recombinant Proteins; D013997:Time Factors
chemical_list: D015703:Antigens, CD; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000069585:Filgrastim